Gilead Sciences said on Monday its experimental HIV treatment was found to be statistically non-inferior to its top-selling ...

Charlie Sheen reveals an experimental HIV drug that "never made it to market" and discusses his sobriety journey since 2017 ...

Gilead Sciences said on Monday its experimental HIV treatment met the main goal and was found to be statistically ...

With a second late-stage trial win for its investigational HIV combo in the books, Gilead Sciences is moving full steam ahead ...

Paper in @jclinicalinvest (bit.ly/497z6jo) by @HopkinsMedicine @JHUMed_ID finds patient living w/ #HIV has dramatic drop in ...

Knowable Magazine reports on breakthroughs in HIV treatment; engineered antibodies show promise for long-term control, ...

Reflecting on his diagnosis, Charlie Sheen questions why a medication he once used never became widely available.

When you’re living with HIV, there are a few health markers that your doctor will use to keep track of your care. One of them ...

HIV and tuberculosis (TB) treatment programs have always relied on clinical trials to understand whether treatment ...

Compounding that statistic, prior studies indicate some trans people at high risk for HIV transmission are hesitant to take ...

The tools to stop the spread of HIV are readily available, but experts said they're not getting to the right people.

Advancements in HIV/AIDS research, drug development and clinical practice since the 1980s have made it possible for people ...